Purdue Institute for Drug Discovery

LT103

Overview: 

SYK inhibitor for the treatment of sickle cell disease and Acute Myeloid Leukemia (AML)

Status: 

Purdue Faculty: 

Dr. Madduri Srinivasarao

Dr. Phil Low

Development Partner: 

Low Institute for Therapeutics